This inventor holds 1 USPTO granted patent. Top assignee: Instytut Farmaceutyczny. Active years: 2011.
Company Filing History:
Years Active: 2011
Title: Piotr Golebiewski: Innovator in Pharmaceutical Chemistry
Introduction
Piotr Golebiewski is a notable inventor based in Warsaw, Poland. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of biologically active compounds. His work has implications for various therapeutic applications, showcasing his expertise and innovative spirit.
Latest Patents
Golebiewski holds a patent for a process related to the preparation of 13,14-dihydro-PGF2 alpha derivatives. This invention pertains to a method for synthesizing compounds represented by a specific general formula, which are valuable biologically active substances or intermediates. The patent emphasizes the preparation of 13,14-dihydro-15(R)-17-substituted-18,19,20-trinor-PGF, commonly known as latanoprost. This compound has important applications in medicine, particularly in treating eye conditions.
Career Highlights
Golebiewski is affiliated with the Pharmaceutical Institute, where he has been involved in various research projects. His work has not only advanced the understanding of pharmaceutical compounds but has also contributed to the development of new therapeutic agents. His dedication to research and innovation has established him as a respected figure in his field.
Collaborations
Throughout his career, Golebiewski has collaborated with several professionals, including Jacek Martynow and Julita Szyc. These collaborations have fostered a productive research environment, leading to advancements in pharmaceutical chemistry.
Conclusion
Piotr Golebiewski's contributions to the field of pharmaceutical chemistry, particularly through his patent on 13,14-dihydro-PGF2 alpha derivatives, highlight his innovative approach to drug development. His work continues to influence the pharmaceutical industry and improve therapeutic options for patients.